Citigroup
IDIX

Citigroup’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Citigroup’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-82,286
Closed -$1.98M – 7591
2014
Q2 		$1.98M Buy
82,286
+53,704
+188% +$560K ﹤0.01% 2481
2014
Q1 		$172K Sell
28,582
-13,620
-32% -$95K ﹤0.01% 4492
2013
Q4 		$252K Buy
42,202
+14,207
+51% +$65.7K ﹤0.01% 4459
2013
Q3 		$146K Buy
27,995
+15,845
+130% +$69.4K ﹤0.01% 4430
2013
Q2 		$44K Buy
+12,150
New +$49.7K ﹤0.01% 5456

Citigroup's IDIX Position: Q3 2014 in Review

Citigroup sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 82,286 shares — an estimated $1.98M sold.

Citigroup first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $1.98M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Citigroup reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Citigroup sold 82,286 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $1.98M.
  • Citigroup first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Citigroup's IDENIX PHARMACEUTICALS INC position peaked at $1.98M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Citigroup's 13F filing for Q3 2014, filed 14 Nov 2014.